Abbott India Ltd.

ABBOTINDIA

Market Cap
₹57,465 Cr.
P/E
47.84

Abbott India Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

3 No

Negative for this company

1 No Data

Insufficient data to analyse

ROE
Latest
29.78%
3yr Average
28.21%
5yr Average
26.29%
Net Profit Margin
Latest
17.75%
3yr Average
16.68%
5yr Average
15.35%
ROCE
Latest
38.7%
3yr Average
36.37%
5yr Average
34.73%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
0% (as of Jul 22)
Anti - Diabetes - Market Share
0.67% (as of Jul 22)
Anti-Infectives - Market Share
0.02% (as of Nov 20)
Antineo Plastic - Market Share
1.96% (as of May 19)
Blood Related - Market Share
0.32% (as of Jul 22)
Cardiovascular - Market Share
32.40% (as of Mar 19)
Creon - Market Share
locked Source
0.61% (as of Nov 21)
Dermatology - Market Share
13.30% (as of Mar 19)
Digene - Market Share
locked Source
13.90% (as of Mar 19)
Duphalac - Market Share
locked Source
25.50% (as of Mar 19)
Duphaston - Market Share
locked Source
13.36% (as of Nov 21)
Endocrinology - Market Share
7.85% (as of Jul 22)
Gastro-Intestinal - Market Share
5.35% (as of Nov 21)
Gynecology - Market Share
63.40% (as of Mar 19)
Influvac - Market Share
locked Source
4.90% (as of Nov 21)
Neurological - Market Share
0.44% (as of Nov 21)
Pain - Market Share
6.20% (as of Dec 22)
Pharmaceutical Sector - Market Share
0.08% (as of Nov 21)
Respiratory - Market Share
0% (as of Jul 22)
Sex Stimulants - Market Share
0.02% (as of Apr 20)
Stomatological - Market Share
51.60% (as of Mar 19)
Thyronorm - Market Share
locked Source
16.70% (as of Mar 19)
Udiliv - Market Share
locked Source
1.81% (as of Jul 22)
Vaccines - Market Share
30.80% (as of Mar 19)
Vertin - Market Share
locked Source
4.51% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Acute vs Chronic

Latest
|
locked
Historic

Dosage Form Break-Up

locked
Source
|
Latest
|
locked
Historic

Brand Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Brands
    Brufen
    Cremaffin Plus
    Digene
    Duphalac
    Duphaston
    Thyronorm
    Zolfresh
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis
    Abbott India Ltd.
    View the discussion on ValuePickr
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Phama Industry - Terminologies and Value Chain - Alpha Invesco
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    timeline